Q32（消毒・滅菌） この度本院感染防止対策委員会
Contents
1.2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16. 1 OWA 01 2 10A M 3 OXM 01A 4 FW 1000M S 1000 50ppm ml 0 1 pH 1 150 508 520 1994 2 10 129 134 1995 3 II 9 7 12 1994 4 CINICIAN 4421 94 950 1995 5 212 14 191 1995 6 INFECTION CONTROL 5 3 318 324 1996 47
17. 0 2 2 Burkholderia cepacia 8 0 1 24 718 0 1 100 100 100 10 24
18. 40 MRSA COPD MRSA VRE in vitro HIV RS B MRSA 60 90w CDC 60 90 60 MRSA 90 8 21 157 1 157 http www 1 mhlw go jp h
19. 06 1 125 25 18 85 C30 15747 MRSA HIV STD A 157 26 2 85 C 30 1 55 C 2 65 C 85 C 4 80 C 20 P45 64
20. MRSA A 102 MRSA MRSA MRSA MRSA MRSA DNA DNA i MRSA MRSA 1 ISBN4 8404 0252 3 2 Infection Contorl2001 MRSA ISBN 4 8404 0076 8 3 Q amp A 200 ISBN 4 263 20158 2 4 ISBN4 8404 0486 0 MRSA 1 Kikuchi K Mupirocin resistant MRSA in J apan 59 724 727 2001 2 Watanabe H Masaki H Asoh N et al Emergence and spread of low level mupirocin resistance in methicillin resistant Staphylococcus aureus isolated
21. CDC
22. 58
23. 70 2 80 C10 100ppm u 1 Clinical Engineering 2001 12 5 413 415 2 2001 37 47 3 1 INFECTION CONTROL 2000 9 12 1304 1309 4 0911 0852 2000 9 11 5 1999 Q amp A 2001 54
24. WHO 1 10 000ppm 5 0 5 5 000ppm 1 0 20 0 5 0 2 0 5 718 1 10 000 5 1 CDC Vol 200 209 213 1999 2 A J Mangram et al Guideline for Prevention of Surgical Site Infection AJIC Vol 27 97 132 1999 3 61 66 1999 49
25. 101 15 70 24 24 101 15 3 2 30 70 30 80 70 10 ml 80 10 39 social handwashing 30 hygienic handwashing
26. ICT Compromised host 59 Guideline for prevention of nosocomial pneumonia MMWR 46 RR 1
27. 63
28. b 80 C10 A 4 2 a b 0 1 51 15 65
29. CDC 2 69
30. 24 bursting bubble HME wick vapor phase 24 CDC American society of Anesthesiology 62
31. 52 80 10 Treponema pallidum TPHA RPR STS 53
32. MRSA 0 1 30 10 0 1 80 C 40 0 1 30 80 C 40 HBs 0 1 30 10 0 1 0 1 80 C 40 0 1 0 1 2 0 1 80 C 40 43 0 1 30 40 MRSA
33. MRSA HCV SA HCV MRSA VRE 80 C Al MRSA VR Bill 80 C10 MRSA VRE 80 C 10 pH5
34. 0 2 30 0157 7 0 02 0 2
35. 46
36. MRSA 44
37. 30 45 MRSA 70 MRSA
38. 0 65 100 MRSA HCV MRSA MRSA HCV 10 MRSA HCV 10 50
39. 0 2 10 20 Alcaligenes 12662115 Alcaligenes xylosoxidans Burkholderia cepacia Enterobacter cloacae Pseudomonas fluorescens Rastonia pickettii Serratia marcescens Erwinia sp 10 Burkholderia cepacia 10 B cepacia Spaulding APIC Spaulding Spaulding 0 0 200ppm 1 80 C10 67
40. 2 Guideline for the Prevention of Surgical Site Infection 1999 66 A 2 200 30 60 75 W cm sec min 15 40cm 500u W cm 50cm 2 90 26004 Wsec cm 99 9 78004 Wsec 415 1 UV infection control 2 63 68 1993
41. 70 77 81 70 24 24 MRSA B 9 5 6ml 4cmx 4cm 100 72g 120ml lg 5ml 12 250mg 1ml 2ml 1ml 2ml lg 5 6ml 41 42
42. 60 79 1997 180 61
43. surgical handwashing 10 transient skin flora resident skin flora CNS coagulase negative staphylococci 1 80 70 50 9 4009 2009 8009 80 150 7 7094 300 f 50 40
44. 68 CDC Guideline for Preventing the ansmission of Mycobacterium tuberculosis in Health Care Facilities 1994 p78
45. SRSV RNA 30 30 55
46. from a community hospital in Japan J Hosp Infect 47 294 300 2001 3 Udo E E Jacob L E Mathew B The spread of mupirocin resistant methicillin resistant Staphylococcus aureus clone in Kuwait hospitals Acta Trop 80 155 161 2001 4 Krishnan P U Miles K Shetty N Detection of methicillin and mupirocin resistance in Staphylococcus aureus isolates using conventional and molecular methods a descriptive study from a burns unit with high prevalence of MRSA Clin Pathol 55 745 748 2002 48
47. oudou 0908 h0821 1 html 56 4 min 41 C 57
Download Pdf Manuals
Related Search